Conavi Medical Corp.
CNVIF
$0.13
$0.0213.68%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 31.52% | 54.80% | 63.23% | 54.06% | 15.36% |
| Total Depreciation and Amortization | 4.18% | -5.98% | -9.62% | -13.35% | -22.04% |
| Total Amortization of Deferred Charges | -43.98% | -56.17% | -69.67% | -82.15% | -20.99% |
| Total Other Non-Cash Items | -93.76% | -104.57% | -121.15% | -108.34% | -22.79% |
| Change in Net Operating Assets | 141.91% | -218.84% | -145.77% | -182.92% | -133.87% |
| Cash from Operations | 24.05% | -6.53% | 12.75% | -21.48% | -13.89% |
| Capital Expenditure | -119.08% | 84.09% | 81.89% | 87.76% | 61.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -106.48% | -108.49% | -105.87% | 1,396.21% | 1,432.46% |
| Cash from Investing | -121.12% | -110.90% | -108.90% | 508.67% | 499.24% |
| Total Debt Issued | -- | -- | -- | -- | -30.39% |
| Total Debt Repaid | -26.91% | -42.81% | -59.98% | -63.50% | -25.88% |
| Issuance of Common Stock | -45.96% | 127.36% | 19.94% | 369,966.67% | 317,100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -118.80% | -- | -- | -- | -- |
| Cash from Financing | -70.74% | 60.63% | -2.77% | 265.08% | 45.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -207.30% | 289.50% | -31.54% | 139.08% | 868.84% |